Trial intelligence / Profile preview

Effects of GH on Muscle in GHD

NCT03878992Unknown

Sponsor
Aarhus University
Start
Apr 2019
Primary completion
Mar 2021
Modality
Hormone, rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

Open-label, single-arm trial of somatropin in growth hormone deficiency (GHD), sponsored by Aarhus University. Primary endpoint: Phosphorylation of Akt in muscle biopsies at 1.5 years. Status: unknown.

02

Drugs

somatropin
03

Conditions

growth hormone deficiency (GHD)

Beyond the preview

Go deeper on NCT03878992.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03878992.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call